Hero-Burman consortium set to buy Fortis Healthcare as board gives thumbs-up
The Munjal-Burmans combine had given their revised offer on May 1, which included an upfront equity infusion of Rs 800 crore at a price of Rs 167 per share into the company through preferential allotment, it added.
The recommendation of the Board would be placed before the shareholders for their approval. Image source: Reuters